1. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion
    Yifat Koren Carmi et al, 2020, IJMS CrossRef
  2. The potential roles of exosomal noncoding RNAs in osteosarcoma
    Shenglong Li et al, 2020, J Cell Physiol CrossRef
  3. RFX1: a promising therapeutic arsenal against cancer
    Joby Issac et al, 2021, Cancer Cell Int CrossRef
  4. Exosomes: Isolation, characterization, and biomedical applications
    Ghadi N. Alzhrani et al, 2021, Cell Biol Int CrossRef
  5. Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy
    Zixuan Sun et al, 2021, Stem Cells International CrossRef
  6. Exosomes from mesenchymal stem cells expressing microribonucleic acid-125b inhibit the progression of diabetic nephropathy via the tumour necrosis factor receptor-associated factor 6/Akt axis
    Xia Cai et al, 2021, Endocr J CrossRef
  7. Mesenchymal Stem Cells in Adipose Tissue and Extracellular Vesicles in Ovarian Cancer Patients: A Bridge toward Metastatic Diffusion or a New Therapeutic Opportunity?
    Gabriele Storti et al, 2021, Cells CrossRef
  8. Inter-regulatory role of microRNAs in interaction between viruses and stem cells
    Afsoon Afshari et al, 2021, WJSC CrossRef
  9. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer
    Bowen Diao et al, 2021, Pathol. Oncol. Res. CrossRef
  10. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C
    Jin Liu et al, 2021, J Cancer Res Clin Oncol CrossRef
  11. Exosomal miR-4488 and miR-1273g-5p inhibit the epithelial-mesenchymal transition of transforming growth factor β2-mediated retinal pigment epithelial cells by targeting ATP-binding cassette A4
    Hongtao Dong et al, 2021, Bioengineered CrossRef
  12. Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer
    Yu Zhang et al, 2021, Front. Oncol. CrossRef
  13. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
    Miaomiao Ye et al, 2022, Molecular Therapy - Oncolytics CrossRef
  14. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications
    Carla Vicinanza et al, 2022, WJSC CrossRef
  15. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis
    Xiaowen Chen et al, 2022, Cell Death Dis CrossRef
  16. p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
    Leonel Cardozo de Menezes e Souza et al, 2022, Membranes CrossRef
  17. Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
    E. Ivanova et al, 2022, Non-coding RNA Research CrossRef
  18. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs
    Ghufran Mohammed Hussein et al, 2022, International Journal of Biological Macromolecules CrossRef
  19. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics
    Mengyu Chen et al, 2022, Ther Adv Med Oncol CrossRef
  20. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
    Zhengjun Lin et al, 2022, Mol Cancer CrossRef
  21. Natural products exert anti-tumor effects by regulating exosomal ncRNA
    Shuang Hu et al, 2022, Front. Oncol. CrossRef
  22. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
    Qiurong Yang et al, 2022, Advanced Science CrossRef
  23. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells (BMSCs) Inhibit the Invasion and Metastasis of Ovarian Cancer by Regulating Epithelial-Mesenchymal Transition Under Hypoxic Microenvironment
    Yingfeng Xu et al, 2022, j biomater tissue eng CrossRef
  24. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment
    MingHua Cui et al, 2022, Front. Immunol. CrossRef
  25. Oral Cancer Stem Cell-Derived Small Extracellular Vesicles Promote M2 Macrophage Polarization and Suppress CD4+ T-Cell Activity by Transferring UCA1 and Targeting LAMC2
    Lan Wu et al, 2022, Stem Cells International CrossRef
  26. Mesenchymal stromal/stem cell-derived exosomes and genitourinary cancers: A mini review
    Aria Salehpour et al, 2023, Front. Cell Dev. Biol. CrossRef
  27. Exosomal transfer of miR-195-5p restrains lung adenocarcinoma progression
    Yongchun Zhou et al, 2023, Experimental Cell Research CrossRef
  28. HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response
    Mehrdad Hashemi et al, 2023, Pharmacological Research CrossRef
  29. Clinical Application of Small Extracellular Vesicles in Gynecologic Malignancy Treatments
    Fei Zheng et al, 2023, Cancers CrossRef
  30. The Application of Exosomes in the Diagnosis and Treatment of Renal Cell Carcinoma
    Xian Zhao et al, 2023, Asia-Pac J Oncol CrossRef
  31. miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy
    Arsinoe C. Thomaidou et al, 2023, IJMS CrossRef
  32. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression: a comprehensive review
    Leiguang Ye et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  33. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
    Jacek R. Wilczyński et al, 2023, Front. Oncol. CrossRef
  34. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance
    Marta Ostrowska-Lesko et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  35. miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration
    Rui Chen et al, 2023, Molecular Therapy - Oncolytics CrossRef
  36. Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells
    Maristella Canovai et al, 2023, Cell Death Discov. CrossRef
  37. Role of microRNA-146a in Cancer Development by Regulating Apoptosis
    Keihan Kookli et al, 2023, Pathology - Research and Practice CrossRef
  38. Dual-functional extracellular vesicles enable synergistic treatment via m6A reader YTHDF1-targeting epigenetic regulation and chemotherapy
    Rong Du et al, 2023, Nano Res. CrossRef
  39. Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?
    Lujian Zhu et al, 2024, JIR CrossRef
  40. Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells
    Chengling Fan et al, 2024, Biochemistry and Biophysics Reports CrossRef
  41. The therapeutic effects of exosomes the first time isolated from pancreatic islet-derived progenitor cells in the treatment of pancreatic cancer
    Imren Hasoglu et al, 2024, Protoplasma CrossRef
  42. Extracellular Vesicles: Translational Agenda Questions for Three Protozoan Parasites
    Kwesi Z. Tandoh et al, 2024, Traffic CrossRef
  43. Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers
    Changfen Xu et al, 2024, Front. Oncol. CrossRef
  44. HER2 Puzzle Pieces: Non-Coding RNAs as Keys to Mechanisms, Chemoresistance, and Clinical Outcomes in Ovarian Cancer
    Fangwei Yang et al, 2024, Pathology - Research and Practice CrossRef
  45. Understanding exosomes: Part 1—Characterization, quantification and isolation techniques
    Richard J. Miron et al, 2024, Periodontology 2000 CrossRef
  46. Exosomes in diagnostic and therapeutic applications of ovarian cancer
    Dhaval Bhavsar et al, 2024, J Ovarian Res CrossRef
  47. Advances in Mesenchymal Stem Cell-Derived Exosomes in Tumor Therapy
    琦玉 王, 2024, ACM CrossRef
  48. Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Xudong Li et al, 2024, Genes & Diseases CrossRef
  49. Cancer-associated adipocytes in the ovarian cancer microenvironment
    Qiuling Cai, 2024, Am J Cancer Res CrossRef
  50. Unveiling the multifaceted roles of microRNAs in extracellular vesicles derived from mesenchymal stem cells: implications in tumor progression and therapeutic interventions
    Sujia Hu et al, 2024, Front. Pharmacol. CrossRef
  51. The Role and Applications of Exosomes in Gynecological Cancer: A Review
    Kai-Hung Wang et al, 2023, Cell Transplant CrossRef
  52. LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a.
    Rui Hou et al, 2021, Cancer Cell Int CrossRef
  53. Mesenchymal stem cells: Guardians of women's health
    Guanwen Gao et al, 2024, Regenerative Therapy CrossRef
  54. Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment
    Long Zheng et al, 2024, Cancer Drug Resist CrossRef
  55. MicroRNAs And Long Non-Coding RNAs In T-Cell Lymphoma: Mechanisms, Pathway, Therapeutic Opportunities
    Mohammed H. Abu-Alghayth et al, 2024, Pathology - Research and Practice CrossRef
  56. A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma
    Kristina S. Komitova et al, 2024, IJMS CrossRef
  57. Exosomes in ovarian cancer: impact on drug resistance and advances in SERS detection techniques
    Biqing Chen et al, 2024, Journal of Pharmaceutical Analysis CrossRef
  58. Emerging roles of exosomes in diagnosis, prognosis, and therapeutic potential in ovarian cancer: a comprehensive review
    Thunwipa Tuscharoenporn et al, 2025, Cancer Gene Ther CrossRef